IMPACT OF HORMONAL BIOMARKERS ON RESPONSE TO HORMONAL THERAPY IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER. VAN Weelden WJ, Lalisang RI, Bulten J, Lindemann K, et al. Am J Obstet Gynecol 2021 May 18. pii: S0002-9378(21)00554.

Read + Share

Amedeo Smart

Independent Medical Education

VAN Weelden WJ, Lalisang RI, Bulten J, Lindemann K, et al. IMPACT OF HORMONAL BIOMARKERS ON RESPONSE TO HORMONAL THERAPY IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER. Am J Obstet Gynecol 2021 May 18. pii: S0002-9378(21)00554.
PMID: 34019887